search
Back to results

Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation (PRACOM1)

Primary Purpose

Prader-Willi Syndrome

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Questionnaires
t-VNS
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Prader-Willi Syndrome focused on measuring Emotion, Cognition

Eligibility Criteria

9 Years - 15 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age from 9 to 15 years old
  • Prader-Willi syndrome with identified genotype.
  • No psychiatric disorder neither PWS.
  • Severe global symptomatology attested by a CGI-S score

Exclusion Criteria:

  • Identified psychiatric or behavioral disorders
  • Severe visual or hearing impairment.
  • Sleep apnea syndrome treated with non-invasive ventilation,
  • Epileptic seizures
  • Cardiac disorders.

Sites / Locations

  • University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

children with PWS

non affected children

Arm Description

Evaluation of cognitive abilities of children with PWS by several cognitive tasks and neuropsychological tests.

Evaluation of cognitive abilities of children with PWS compared to a non-pathologic population of children by several cognitive tasks and neuropsychological tests

Outcomes

Primary Outcome Measures

assessment of the level of emotional control
composite score of emotional control level of children with PWS composed of scores of emotional lability

Secondary Outcome Measures

Evaluation of behavioral disorders of children with PWS by CBCL (Child Behavior Checklist) scale
CBCL (Child Behavior CheckList) scale: is a questionnaire comprising 1) an adaptive functioning scale (activities, social and school spheres), 2) a syndrome scale (social withdrawal, anxiety / depression, somatic complaints, social problems, thinking problems, attention problems, behavior problems and aggressiveness; total of internalized problems and total of externalized problems), 3) a DSM-oriented scale (Lengua et al., 2001; anxiety, attention problems / hyperactivity, behavior problems, depression, opposition / mistrust, social problems / immaturity, somatization). (duration = 20 ') - there is no minimum and maximum values as this is an evaluation of behavioral disorders
Evaluation of behavioral disorders of children with PWS by Hyperphagia Questionnaire
HQ-CT (Hyperphagia Questionnaire) scale: The HQ-CT (Hyperphagia Questionnaire for Use in Prader-Willi Syndrome Clinical Trials, Fehnel et al., 2015, appendix 10) is a scale derived from the Dykens hyperphagia questionnaire (Dykens et al., 2007). The specificity of the Dykens questionnaire makes it a favored tool in the international literature in the evaluation of the eating behavior of patients with PWS (Crain, 2010). The HQ-CT was created specifically to assess the eating behavior of these patients in clinical trials. It consists of 9 items for which a person taking care of the patient (family or caregiver) indicates the frequency and severity of the behavior described on a 5-point Likert scale (with 1 = absence of the behavior and 5 = very frequent behavior or severe) (⍺ = .91). (duration = 5 ') - so 1 is the minimum value and 5 the maximum value and higher scores mean a worse outcome
Evaluation of cognitive abilities of children with PWS
emotional language task
Test of evaluation of cognitive abilities
multimodal emotional recognition test MERT
Evaluation of cognitive abilities
WISC-V

Full Information

First Posted
March 3, 2020
Last Updated
August 22, 2023
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT04526379
Brief Title
Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
Acronym
PRACOM1
Official Title
Communication in Prader-Willi Syndrome: Study of Emotional Control Related to Behavioral Disorders, Their Daily Repercussions and Examination of an Innovative Therapy: Transcutaneous Electrical Nerve Stimulation of the Vagus Nerve - PRACOM1
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
September 7, 2020 (Actual)
Primary Completion Date
December 7, 2020 (Actual)
Study Completion Date
April 27, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The present project project is divided in two parts. The primary aim of the part 1 of this study is to evaluate emotional control abilities of children with Prader-Willi syndrome (PWS) aged from 9 to 15 years and to study repercussions of this supposed lack of abilities on cognitive capacities and behavioral troubles. The study also evaluate influence of the emotional symptomatology of patients on quality of parents' life and on the care of parents and scholar/institutional caregivers. In the second part of this study, the study evaluate the feasibility and the tolerance to a non-invasive device supposed to reduce emotional symptoms in this disease.
Detailed Description
Prader-Willi Syndrome (PWS) is a rare genetic disorder involving a variety of clinical, behavioral and cognitive symptoms. 83 to 97% of patients have episodes of temper tantrum, associated with an important emotional lability. These different cognitive and behavioral limitations are barriers to the social integration of patients. The PWS also has repercussions on well-being and quality of life of the family. Thus, the present project focuses on the characteristics of emotional control related to the anger of children with PWS and its behavioral, cognitive and social implications. In addition, at a therapeutic level, our project assumes that transcutaneous electrical nerve stimulation (t-VNS), a non-invasive, safe and inexpensive method, could be effective in reducing the severity of behavioral disorders such as temper tantrums while improving cognitive performance and social communication in the PWS.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prader-Willi Syndrome
Keywords
Emotion, Cognition

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study consists of 2 parts. The first part compares 30 children with PWS compared to 30 control children without PWS. The second part will be based on 12 children with PWS who have undergone part 1.
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
children with PWS
Arm Type
Experimental
Arm Description
Evaluation of cognitive abilities of children with PWS by several cognitive tasks and neuropsychological tests.
Arm Title
non affected children
Arm Type
Other
Arm Description
Evaluation of cognitive abilities of children with PWS compared to a non-pathologic population of children by several cognitive tasks and neuropsychological tests
Intervention Type
Behavioral
Intervention Name(s)
Questionnaires
Intervention Description
Evaluation of behavioral disorders of children with PWS by questionnaires
Intervention Type
Device
Intervention Name(s)
t-VNS
Intervention Description
Evaluation of the influence of 6 month-stimulation by t-VNS on emotional, cognitive, and behavioral/clinical characteristics of 12 children with PWS on 30 PWS patients included.
Primary Outcome Measure Information:
Title
assessment of the level of emotional control
Description
composite score of emotional control level of children with PWS composed of scores of emotional lability
Time Frame
day 0
Secondary Outcome Measure Information:
Title
Evaluation of behavioral disorders of children with PWS by CBCL (Child Behavior Checklist) scale
Description
CBCL (Child Behavior CheckList) scale: is a questionnaire comprising 1) an adaptive functioning scale (activities, social and school spheres), 2) a syndrome scale (social withdrawal, anxiety / depression, somatic complaints, social problems, thinking problems, attention problems, behavior problems and aggressiveness; total of internalized problems and total of externalized problems), 3) a DSM-oriented scale (Lengua et al., 2001; anxiety, attention problems / hyperactivity, behavior problems, depression, opposition / mistrust, social problems / immaturity, somatization). (duration = 20 ') - there is no minimum and maximum values as this is an evaluation of behavioral disorders
Time Frame
month 6
Title
Evaluation of behavioral disorders of children with PWS by Hyperphagia Questionnaire
Description
HQ-CT (Hyperphagia Questionnaire) scale: The HQ-CT (Hyperphagia Questionnaire for Use in Prader-Willi Syndrome Clinical Trials, Fehnel et al., 2015, appendix 10) is a scale derived from the Dykens hyperphagia questionnaire (Dykens et al., 2007). The specificity of the Dykens questionnaire makes it a favored tool in the international literature in the evaluation of the eating behavior of patients with PWS (Crain, 2010). The HQ-CT was created specifically to assess the eating behavior of these patients in clinical trials. It consists of 9 items for which a person taking care of the patient (family or caregiver) indicates the frequency and severity of the behavior described on a 5-point Likert scale (with 1 = absence of the behavior and 5 = very frequent behavior or severe) (⍺ = .91). (duration = 5 ') - so 1 is the minimum value and 5 the maximum value and higher scores mean a worse outcome
Time Frame
month 6
Title
Evaluation of cognitive abilities of children with PWS
Description
emotional language task
Time Frame
2 days
Title
Test of evaluation of cognitive abilities
Description
multimodal emotional recognition test MERT
Time Frame
2 days
Title
Evaluation of cognitive abilities
Description
WISC-V
Time Frame
2 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
9 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age from 9 to 15 years old Prader-Willi syndrome with identified genotype. No psychiatric disorder neither PWS. Severe global symptomatology attested by a CGI-S score Exclusion Criteria: Identified psychiatric or behavioral disorders Severe visual or hearing impairment. Sleep apnea syndrome treated with non-invasive ventilation, Epileptic seizures Cardiac disorders.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maithé TAUBER, MD
Organizational Affiliation
University Hospital, Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital
City
Toulouse
Country
France

12. IPD Sharing Statement

Learn more about this trial

Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation

We'll reach out to this number within 24 hrs